Skip to main content
Top
Published in: Infection 3/2017

01-06-2017 | Case Report

Hints for control of infection in unique extrahepatic vertebral alveolar echinococcosis

Authors: Jean-François Faucher, Cécile Descotes-Genon, Bruno Hoen, Joël Godard, Sophie Félix, Sébastien Aubry, Oleg Blagosklonov, Frédéric Grenouillet, Marie-Pascale Brientini, Carine Richou, Solange Bresson-Hadni, Catherine Chirouze

Published in: Infection | Issue 3/2017

Login to get access

Abstract

The prognosis of vertebral alveolar echinococcosis (AE) is poor. We report on the unique outcome of a patient with preexisting liver cirrhosis, in whom a diagnosis of vertebral AE was established on vertebral histopathology (D4 corporectomy in 2010 for paraplegia). Therapeutic drug monitoring of albendazole (ABZ) showed that a low dosage was appropriate. The patient recovered and ABZ withdrawal was decided in 2014, with no relapse 18 months later. In this patient, infection was purely or mainly localized in the dorsal spine, and this may have been favored by liver cirrhosis. A longer follow-up is, however, needed to confirm cure.
Literature
1.
go back to reference Keutgens A, Simoni P, Detrembleur N, Frippiat F, Giot JB, Spirlet F, Aghazarian S, Descy J, Meex C, Huynen P, Melin P, Müller N, Gottstein B, Carlier Y, Hayette MP. Fatal alveolar echinococcosis of the lumbar spine. J Clin Microbiol. 2013;51:688–91.CrossRefPubMedPubMedCentral Keutgens A, Simoni P, Detrembleur N, Frippiat F, Giot JB, Spirlet F, Aghazarian S, Descy J, Meex C, Huynen P, Melin P, Müller N, Gottstein B, Carlier Y, Hayette MP. Fatal alveolar echinococcosis of the lumbar spine. J Clin Microbiol. 2013;51:688–91.CrossRefPubMedPubMedCentral
2.
go back to reference Nourrisson C, Mathieu S, Beytout J, Cambon M, Poirier P. Osteolytic bone lesion: vertebral alveolar echinococcosis in a patient with splenectomy. Rev Med Interne. 2014;35:399–402.CrossRefPubMed Nourrisson C, Mathieu S, Beytout J, Cambon M, Poirier P. Osteolytic bone lesion: vertebral alveolar echinococcosis in a patient with splenectomy. Rev Med Interne. 2014;35:399–402.CrossRefPubMed
3.
go back to reference Nell M, Burgkart RH, Gradl G, von Eisenhart-Rothe R, Schaeffeler C, Nell M, Burgkart RH, Gradl G, von Eisenhart-Rothe R, Schaeffeler C, Trappe D, da Costa CP, Gradinger R, Kirchhoff C. Primary extrahepatic alveolar echinococcosis of the lumbar spine and the psoas muscle. Ann Clin Microbiol Antimicrob. 2011;10:13.CrossRefPubMedPubMedCentral Nell M, Burgkart RH, Gradl G, von Eisenhart-Rothe R, Schaeffeler C, Nell M, Burgkart RH, Gradl G, von Eisenhart-Rothe R, Schaeffeler C, Trappe D, da Costa CP, Gradinger R, Kirchhoff C. Primary extrahepatic alveolar echinococcosis of the lumbar spine and the psoas muscle. Ann Clin Microbiol Antimicrob. 2011;10:13.CrossRefPubMedPubMedCentral
4.
go back to reference Toussaint F, Pere P, Le Chaffotec L, Grandhaye P, Pourel J, Chary-Valckenaere I. Alveolar echinococcosis of the spine. J Clin Rheumatol. 2001;7:248–51.CrossRefPubMed Toussaint F, Pere P, Le Chaffotec L, Grandhaye P, Pourel J, Chary-Valckenaere I. Alveolar echinococcosis of the spine. J Clin Rheumatol. 2001;7:248–51.CrossRefPubMed
5.
go back to reference Georges S, Villard O, Filisetti D, Mathis A, Marcellin L, Hansmann Y, Candolfi E. Usefulness of PCR analysis for diagnosis of alveolar echinococcosis with unusual localizations: two case studies. J Clin Microbiol. 2004;42:5954–6.CrossRefPubMedPubMedCentral Georges S, Villard O, Filisetti D, Mathis A, Marcellin L, Hansmann Y, Candolfi E. Usefulness of PCR analysis for diagnosis of alveolar echinococcosis with unusual localizations: two case studies. J Clin Microbiol. 2004;42:5954–6.CrossRefPubMedPubMedCentral
6.
go back to reference Scheuring UJ, Seitz HM, Wellmann A, Hartlapp JH, Tappe D, Brehm K, Spengler U, Sauerbruch T, Rockstroh JK. Long-term benzimidazole treatment of alveolar echinococcosis with hematogenic subcutaneous and bone dissemination. Med Microbiol Immunol. 2003;192:193–5.CrossRefPubMed Scheuring UJ, Seitz HM, Wellmann A, Hartlapp JH, Tappe D, Brehm K, Spengler U, Sauerbruch T, Rockstroh JK. Long-term benzimidazole treatment of alveolar echinococcosis with hematogenic subcutaneous and bone dissemination. Med Microbiol Immunol. 2003;192:193–5.CrossRefPubMed
7.
go back to reference Merkle EM, Kramme E, Vogel J, Krämer S, Schulte M, Usadel S, Kern P, Brambs HJ. Bone and soft tissue manifestations of alveolar echinococcosis. Skeletal Radiol. 1997;26:289–92.CrossRefPubMed Merkle EM, Kramme E, Vogel J, Krämer S, Schulte M, Usadel S, Kern P, Brambs HJ. Bone and soft tissue manifestations of alveolar echinococcosis. Skeletal Radiol. 1997;26:289–92.CrossRefPubMed
8.
go back to reference Claudon M, Bracard S, Plenat F, Regent D, Bernadac P, Picard L. Spinal involvement in alveolar echinococcosis: assessment of two cases. Radiology. 1987;162:571–2.CrossRefPubMed Claudon M, Bracard S, Plenat F, Regent D, Bernadac P, Picard L. Spinal involvement in alveolar echinococcosis: assessment of two cases. Radiology. 1987;162:571–2.CrossRefPubMed
9.
go back to reference Brunetti E, Kern P, Vuitton DA. Writing panel for the WHO-IWGE expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1–16.CrossRefPubMed Brunetti E, Kern P, Vuitton DA. Writing panel for the WHO-IWGE expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop. 2010;114:1–16.CrossRefPubMed
10.
go back to reference Reuter S, Seitz HM, Kern P, Junghanss T. Extrahepatic alveolar echinococcosis without liver involvement: a rare manifestation. Infection. 2000;28:187–92.CrossRefPubMed Reuter S, Seitz HM, Kern P, Junghanss T. Extrahepatic alveolar echinococcosis without liver involvement: a rare manifestation. Infection. 2000;28:187–92.CrossRefPubMed
11.
go back to reference Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. European echinococcosis registry. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis. 2003;9:343–9.CrossRefPubMedPubMedCentral Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann RW, Vuitton DA, Kern P. European echinococcosis registry. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982–2000. Emerg Infect Dis. 2003;9:343–9.CrossRefPubMedPubMedCentral
12.
go back to reference Crouzet J, Grenouillet F, Delabrousse E, Blagosklonov O, Thevenot T, Di Martino V, Piarroux R, Mantion GA, Bresson-Hadni S. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. Clin Microbiol Infect. 2010;16:788–91.CrossRefPubMed Crouzet J, Grenouillet F, Delabrousse E, Blagosklonov O, Thevenot T, Di Martino V, Piarroux R, Mantion GA, Bresson-Hadni S. Personalized management of patients with inoperable alveolar echinococcosis undergoing treatment with albendazole: usefulness of positron-emission-tomography combined with serological and computed tomography follow-up. Clin Microbiol Infect. 2010;16:788–91.CrossRefPubMed
13.
go back to reference Ammann RW, Stumpe KD, Grimm F, Deplazes P, Huber S, Bertogg K, Fischer DR, Müllhaupt B. Outcome after discontinuing long-term benzimidazole treatment in patients with non-resectable alveolar echinococcosis with negative FDG-PET/CT and anti-EmII/3-10 serology. PLoS Negl Trop Dis. 2015;9:e0003964.CrossRefPubMedPubMedCentral Ammann RW, Stumpe KD, Grimm F, Deplazes P, Huber S, Bertogg K, Fischer DR, Müllhaupt B. Outcome after discontinuing long-term benzimidazole treatment in patients with non-resectable alveolar echinococcosis with negative FDG-PET/CT and anti-EmII/3-10 serology. PLoS Negl Trop Dis. 2015;9:e0003964.CrossRefPubMedPubMedCentral
14.
go back to reference Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, Boulahdour H, Blagosklonov O. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med. 2013;54:358–63.CrossRefPubMed Caoduro C, Porot C, Vuitton DA, Bresson-Hadni S, Grenouillet F, Richou C, Boulahdour H, Blagosklonov O. The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis. J Nucl Med. 2013;54:358–63.CrossRefPubMed
15.
go back to reference Nagy J, Schipper HG, Koopmans RP, Butter JJ, Van Boxtel CJ, Kager PA. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg. 2002;66:260–3.CrossRefPubMed Nagy J, Schipper HG, Koopmans RP, Butter JJ, Van Boxtel CJ, Kager PA. Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. Am J Trop Med Hyg. 2002;66:260–3.CrossRefPubMed
Metadata
Title
Hints for control of infection in unique extrahepatic vertebral alveolar echinococcosis
Authors
Jean-François Faucher
Cécile Descotes-Genon
Bruno Hoen
Joël Godard
Sophie Félix
Sébastien Aubry
Oleg Blagosklonov
Frédéric Grenouillet
Marie-Pascale Brientini
Carine Richou
Solange Bresson-Hadni
Catherine Chirouze
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-016-0974-z

Other articles of this Issue 3/2017

Infection 3/2017 Go to the issue